Abstract CT025: BT8009-100 phase I/II study of novel bi-cyclic peptide and MMAE conjugate BT8009 in patients with advanced malignancies associated with nectin-4 expression
McKean, Meredith, Baldini, Capucine, Verlingue, Loic, Doger, Bernard, Falchook, Gerald, Italiano, Antoine, Lostes, Julia, Reig, Oscar, Watson, Roshawn, Hazard, Sebastien, Smethurst, Dominic, Fulci, Giulia, Xu, Hongmei, Jeffery, Phil, Lee, Kevin, Braña, Irene, Cousin, Sophie, Fontana, Elisa, Arkenau, Hendrik-Tobias
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article